openserveblockversewordysbillionaire.aiyourlistWhiteboardAppquizieunschool

News

Home
Politics
World
Sports
Markets
Business
Entertainment
Music
Health
Tech
Science
Good News

Want your own hosted, self-optimizing clone of this — or any OpenServe site? Open Development for enterprise →

Privacy Notice Data rights Terms of Service Feedback Cookie NoticeHelp Acceptable Use Copyright AI Notice Your Privacy Choices Subprocessors Data Processing Addendum Installed App Terms Company Solutions Free assessment Investors Get the app Contact

openserveblockversewordysbillionaire.aiyourlistWhiteboardAppquizieunschool

New Journal

News

Home
Politics
World
Sports
Markets
Business
Entertainment
Music
Health
Tech
Science
Good News

Want your own hosted, self-optimizing clone of this — or any OpenServe site? Open Development for enterprise →

Amphenol Details CommScope Culture Shift at Investor Conference — IJR News

Amphenol Details CommScope Culture Shift at Investor Conference

Business

Amphenol Details CommScope Culture Shift at Investor Conference

14 sources·Updated Sep 9, 2026

Several telecommunications and technology companies appeared at investor conferences on September 8–9, 2026, including Verizon, T-Mobile, Amphenol and Twilio. The provided Verizon and T-Mobile excerpts primarily introduce company executives and provide standard disclosure language, without substantive business updates. Amphenol said CommScope is adopting a more decentralized, accountable and aggressive operating culture following its integration into Amphenol, while emphasizing that the transformation will take time. The Twilio excerpt consists only of transcript definitions and disclaimers and contains no business commentary.

Sponsored

In this story:🏢Amphenol🏢CommScope

Where do you stand?

Amphenol

CommScope

Sponsored

Coverage details

R 100%

Left: 00%
Center: 00%
Right: 4100%

More on this story

Back to News

Business

17 Education Posts First Quarterly Profit, Revenue Jumps

17 Education & Technology Group reported its Q2 2026 results with its first-ever quarterly GAAP net profit of RMB1.1 million and non-GAAP profit of RMB4.7 million, as net revenue jumped 254.6% to RMB90.1 million on AI-powered services, with a cash position of RMB456.9 million and a gross margin of 69.2%. The company highlighted expansion of its AI application ecosystem and ongoing investments across education segments, while management cautioned about seasonality and market risks.

7 sources

Finance

Canadian banks cite AI push and stronger equity returns at summit

Scotiabank executives outlined a modernization and efficiency push driven by organic growth and technology, aiming to lift ROE across Canadian and U.S. franchises while maintaining strong capital and risk discipline. They cited solid CET1 buffers, rising ROE across units, expanded U.S. presence and wealth growth plans, and AI-enabled initiatives and selective tuck-in acquisitions to support a higher earnings trajectory.

Other

Total sources14

Last updatedSep 9, 2026

Does this breakdown look right?

Sponsored

How it spread

Broke gurufocus.com · Sep 8, 8:00 PM ET→Right +17h→14 sources +20h on

Claim check

What each side asserts, disputes — or leaves out entirely.

Analyzing the coverage…

Where do you land?

Whose framing of this story rings truest to you?

Sponsored

Coverage

Sponsored

Comments

Ask Genius by OpenServe:

Free account · your comment posts right after signup

Sponsored

15 sources

Sponsored

Business

Lexaria Closes $5.9 Million Warrant Exercise

Lexaria Bioscience announces the immediate cash exercise of 453,969 warrants at a reduced price of $12.92, issuing equal Series A and short-term Series B warrants at $12.67 to raise about $5.9 million in gross proceeds for working capital and ongoing R&D; the deal includes a resale registration and placement arrangement, with the new warrants expiring five years and 18 months respectively. The company also plans to combine these proceeds with a $2.6 million Australian tax rebate to fund operations through 2027, leveraging the DehydraTECH platform to advance its drug-delivery initiatives.

8 sources